Newsletter Subject

Remember this number (write it down)

From

totalwealthresearch.com

Email Address

customerservice@totalwealthresearch.com

Sent On

Mon, Sep 18, 2017 12:03 PM

Email Preheader Text

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiv

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Total Wealth. Your ability to alter your subscription information can be found at the bottom of this email. [Total Wealth] Dear Total Wealth Reader, Hi, Gabe here from VIP Services. We don't have a lot of time. As my boss told you yesterday, our team has been working around the clock to finalize our research regarding this remarkable Texas lab and their "AB4 Vaccine" breakthrough. We're releasing it today... And we're also preparing to hold an exclusive conference call about this quickly developing situation. My phone lines were ringing all weekend about this, and this morning has been no different. So if you couldn't get through, I want to give you one last shot. You can reach me at: 855.509.6600 (or 443.353.4770 for international calls). Don't wait. The AB4 Vaccine has already received FDA approval. In fact, a member of the FDA Advisory Committee who took part in this historic 10-0 vote called it: "the most exciting thing I've seen in my lifetime." And this lab's breakthrough could be the key to it being used to save eight million lives a year. Our investigation suggests a bidding war may be taking place behind the scenes. And we expect a licensing deal will be announced any day now. It could be worth $500 million in a single year. That would instantly represent a 128,866% revenue surge for this small lab. This could be a rare, millionaire-making opportunity. And there is still a small window of time left for you to discover how to get in on the ground floor. So please call me immediately. It's now or never. Again, my number is: 855.509.6600 (or 443.353.4770 for international calls). I'll make sure you get our investment research on this Texas lab and access to our exclusive conference call on this once-in-a-lifetime situation. I look forward to talking to you. Sincerely, Gabe Oropollo Director, VIP Services 855.509.6600 or 443.353.4770 (international) --------------------------------------------------------------- You are receiving this e-mail at, {EMAIL}, as a part of your free subscription to Total Wealth. Remove your email from this list: [Unsubscribe]( To cancel by mail or for any other subscription issues, write us at: Total Wealth | Attn: Member Services | 16 West Madison Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: []( © 2017 Total Wealth All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Total Wealth Research. 16 West Madison Street, Baltimore MD 21201.

Marketing emails from totalwealthresearch.com

View More
Sent On

24/07/2020

Sent On

17/07/2020

Sent On

09/07/2020

Sent On

02/07/2020

Sent On

26/06/2020

Sent On

18/06/2020

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.